Equity Overview
Price & Market Data
Price: $1.33
Daily Change: +$0.01 / 0.75%
Daily Range: $1.32 - $1.33
Market Cap: $2,657,345
Daily Volume: 1,592
Performance Metrics
1 Week: -8.97%
1 Month: -5.71%
3 Months: -39.17%
6 Months: -58.75%
1 Year: -85.29%
YTD: -60.66%
Company Details
Employees: 6
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
PainReform Ltd., a clinical stage specialty pharmaceutical company, focuses on the reformulation of established therapeutics and provides an extended period of post-surgical pain relief in Israel. It develops PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia, as well as in Phase 3 clinical trial for pain treatment of patients undergoing bunionectomy and pain treatment of hernia repair operations. The company was incorporated in 2007 and is based in Tel Aviv, Israel.